D W Gilroy - JoVE Visualize

Showing results (1-10 of 15) with videos related to

Pageof 2

Sort By:

Drug News & Perspectives|July 25, 2003

Cyclooxygenase enzymes as targets for therapeutic intervention in inflammationP R Colville-Nash, D W Gilroy

Journal of Molecular Medicine (Berlin, Germany)|June 27, 2000

New insights into the role of COX 2 in inflammationD W Gilroy, P R Colville-Nash

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001

Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammationP R Colville-Nash, D W Gilroy

European Journal of Pharmacology|October 6, 1998

Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammationD W Gilroy, A Tomlinson, D A Willoughby

Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 16, 1998

Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammationD W Gilroy, A Tomlinson, D A Willoughby

American Journal of Physiology. Cell Physiology|June 13, 2001

COX-2 expression and cell cycle progression in human fibroblastsD W Gilroy, M A Saunders, K K Wu

The Journal of Biological Chemistry|March 30, 2001

Selective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblastsM A Saunders, L Sansores-Garcia, D W Gilroy, et al.

Nature Medicine|December 1, 2001

Possible new role for NF-kappaB in the resolution of inflammationT Lawrence, D W Gilroy, P R Colville-Nash, et al.

Inflammation|October 30, 1998

The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis-induced monoarticular arthritis in the ratD W Gilroy, A Tomlinson, K Greenslade, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001

Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administrationM J Paul-Clark, D W Gilroy, D Willis, et al.

Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:

Pageof 2

Drug News & Perspectives|July 25, 2003

Cyclooxygenase enzymes as targets for therapeutic intervention in inflammationP R Colville-Nash, D W Gilroy

Journal of Molecular Medicine (Berlin, Germany)|June 27, 2000

New insights into the role of COX 2 in inflammationD W Gilroy, P R Colville-Nash

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001

Potential adverse effects of cyclooxygenase-2 inhibition: evidence from animal models of inflammationP R Colville-Nash, D W Gilroy

European Journal of Pharmacology|October 6, 1998

Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammationD W Gilroy, A Tomlinson, D A Willoughby

Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 16, 1998

Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammationD W Gilroy, A Tomlinson, D A Willoughby

American Journal of Physiology. Cell Physiology|June 13, 2001

COX-2 expression and cell cycle progression in human fibroblastsD W Gilroy, M A Saunders, K K Wu

The Journal of Biological Chemistry|March 30, 2001

Selective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblastsM A Saunders, L Sansores-Garcia, D W Gilroy, et al.

Nature Medicine|December 1, 2001

Possible new role for NF-kappaB in the resolution of inflammationT Lawrence, D W Gilroy, P R Colville-Nash, et al.

Inflammation|October 30, 1998

The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis-induced monoarticular arthritis in the ratD W Gilroy, A Tomlinson, K Greenslade, et al.

Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2001

Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administrationM J Paul-Clark, D W Gilroy, D Willis, et al.

Pageof 2